Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Celularity (CELU) Other Accumulated Expenses (2021 - 2025)

Celularity has reported Other Accumulated Expenses over the past 2 years, most recently at $300000.0 for Q4 2025.

Quarterly Other Accumulated Expenses changed N/A to $300000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $300000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $300000.0 for FY2025, N/A changed from the prior year.
Other Accumulated Expenses was $300000.0 for Q4 2025 at Celularity, down from $3.0 million in the prior quarter.
Over five years, Other Accumulated Expenses peaked at $3.0 million in Q3 2021 and troughed at $300000.0 in Q4 2025.